According to a survey from 2023, the availability of sufficient/high quality data was the most often stated barrier to the adoption of artificial intelligence (AI) in drug discovery in high-income countries. Other frequently named barriers included the availability of suitable staff and the lack of understanding of AI. This statistic shows the leading barriers for AI adoption in drug discovery in developed countries.
Leading barriers for AI adoption in drug discovery in high-income countries worldwide as of 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Wellcome Trust, & BCG. (June 19, 2023). Leading barriers for AI adoption in drug discovery in high-income countries worldwide as of 2023 [Graph]. In Statista. Retrieved November 12, 2024, from https://www.statista.com/statistics/1428364/ai-in-drug-discovery-adoption-barriers-in-high-income-countries-worldwide/?utm_campaign=neuralink-implants-brain-chip&utm_medium=referral&utm_source=www.healthaiinsights.com
Wellcome Trust, und BCG. "Leading barriers for AI adoption in drug discovery in high-income countries worldwide as of 2023." Chart. June 19, 2023. Statista. Accessed November 12, 2024. https://www.statista.com/statistics/1428364/ai-in-drug-discovery-adoption-barriers-in-high-income-countries-worldwide/?utm_campaign=neuralink-implants-brain-chip&utm_medium=referral&utm_source=www.healthaiinsights.com
Wellcome Trust, BCG. (2023). Leading barriers for AI adoption in drug discovery in high-income countries worldwide as of 2023. Statista. Statista Inc.. Accessed: November 12, 2024. https://www.statista.com/statistics/1428364/ai-in-drug-discovery-adoption-barriers-in-high-income-countries-worldwide/?utm_campaign=neuralink-implants-brain-chip&utm_medium=referral&utm_source=www.healthaiinsights.com
Wellcome Trust, and BCG. "Leading Barriers for Ai Adoption in Drug Discovery in High-income Countries Worldwide as of 2023." Statista, Statista Inc., 19 Jun 2023, https://www.statista.com/statistics/1428364/ai-in-drug-discovery-adoption-barriers-in-high-income-countries-worldwide/?utm_campaign=neuralink-implants-brain-chip&utm_medium=referral&utm_source=www.healthaiinsights.com
Wellcome Trust & BCG, Leading barriers for AI adoption in drug discovery in high-income countries worldwide as of 2023 Statista, https://www.statista.com/statistics/1428364/ai-in-drug-discovery-adoption-barriers-in-high-income-countries-worldwide/?utm_campaign=neuralink-implants-brain-chip&utm_medium=referral&utm_source=www.healthaiinsights.com (last visited November 12, 2024)
Leading barriers for AI adoption in drug discovery in high-income countries worldwide as of 2023 [Graph], Wellcome Trust, & BCG, June 19, 2023. [Online]. Available: https://www.statista.com/statistics/1428364/ai-in-drug-discovery-adoption-barriers-in-high-income-countries-worldwide/?utm_campaign=neuralink-implants-brain-chip&utm_medium=referral&utm_source=www.healthaiinsights.com